ALBANY MOLECULAR RESEARCH INC (AMRI) has 103 open-market insider trades by 18 insiders since 2006. The most active filer is Steven R. Hagen, VP.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| William S. Marth | CEOPres | — | 9 | $2.4M | 2017-08-31 |
| Steven R. Hagen | VP | — | 55 | $2.1M | 2017-08-31 |
| Constance M. D'Ambra | 10% | — | 3 | $1.0M | 2015-11-09 |
| Thomas E. D'Ambra | Dir | — | 1 | $980K | 2017-08-31 |
| Lori M. Henderson | SecretarySVP | — | 2 | $586K | 2015-11-02 |
| Michael M. Nolan | CFO | — | 3 | $503K | 2015-02-25 |
| George Svokos | COO | — | 3 | $493K | 2017-08-31 |
| Arthur J. Roth | Dir | — | 4 | $207K | 2017-05-26 |
| Kevin Oconnor | Dir | — | 3 | $191K | 2017-08-31 |
| Anthony P. Tartaglia | Dir | — | 1 | $173K | 2009-06-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Anthony J. Maddaluna | Director | Buy | $25K | 2016-12-02 |
| Steven R. Hagen | VP | Sell | $150K | 2016-11-30 |
| Lori M. Henderson | VP & Secretary | Sell | $102K | 2016-11-16 |
| Steven R. Hagen | SVP Manufacturing & Pharmaceut | Sell | $13K | 2016-11-10 |
| Steven R. Hagen | SVP Manufacturing & Pharmaceut | Sell | $21K | 2016-08-09 |
| Kevin Oconnor | Director | Sell | $72K |
Companies that share insiders with AMRI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2016-05-31 |
| William S. Marth | CEO & President | Buy | $161K | 2016-05-16 |
| Steven R. Hagen | SVP Manufacturing & Pharmaceut | Sell | $30K | 2016-05-13 |
| George Svokos | COO | Buy | $160K | 2016-05-13 |
| Constance M. D'Ambra | 10% | Sell | $980K | 2015-11-09 |
| Steven R. Hagen | SVP Manufacturing & Pharmaceut | Sell | $20K | 2015-08-17 |
| Steven R. Hagen | SVP Manufacturing & Pharmaceut | Sell | $105K | 2015-08-07 |
| Thomas E. D'Ambra Ph.D. | Director | Sell | $395K | 2015-06-10 |
| Steven R. Hagen | SVP Manufacturing & Pharmaceut | Sell | $100K | 2015-06-08 |
| William S. Marth | President | Buy | $200K | 2015-06-04 |